
Tuesday, March 13, 2018 12:30:59 PM
Look for the Annual to be out by the end of month. I am sure there will be language towards where the J&J case is standing. We already know that the case was delayed a few times, and J&J has had many opportunities to deliver their side of which if they had something substantial, DECN would have received a Cease and Desist order...This has not happened, so it leads me to believe that DECN truly has a case of their own against J&J for liable and/or interference with a smaller business. Fact is Big Companies such as J&J have "The Inside" with FDA and many government companies because they have been around for a long time and because they make billions in revenue and may "Take care" of employees that may be making job transitions.
Take it for what it is worth, but if DECN does in fact get through the IRB Independent Review Board required testing and gets their 510K application approved by the FDA, market will be open here in the US where Millions will be made. Which does open the door for their other products as well.
Just my two cents, but I will be holding at least through 2018 to see what happens.
Best of Luck everyone!
IMHO
In My Own Personal Opinion Of Course!

Liked By
Spread the love. Be the first to like this post!
TNRG Files A Reg A Offering, To Raise $75 million • TNRG • Feb 1, 2023 10:07 AM
IQST - iQSTEL Announces Board Election and CPA Ratification Following Annual Shareholder Meeting • IQST • Feb 1, 2023 10:04 AM
1606 Corp. (OTC | CBDW) to Produce a New Inventory of CBD Smokables to Supply an Additional 2500 Retail Outlets, Engages Direct Marketing Expert to Head Efforts • CBDW • Feb 1, 2023 8:30 AM
ITRONICS RECEIVES VALUATION REPORT FOR ITS INTELLECTUAL PROPERTY TO OBTAIN NON-DILUTIVE FINANCING • ITRO • Feb 1, 2023 6:30 AM
Kona Gold Beverage, Inc Announces Distribution Agreement with Norman Distribution in Illinois • KGKG • Jan 31, 2023 9:00 AM
PSYC Provides Shareholders with Key Corporate Updates and Highlights Objectives for 2023 • PSYC • Jan 31, 2023 8:30 AM